AMICUS THERAPEUTICS, INC. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Amicus Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q3 2024.
  • Amicus Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending September 30, 2024 was $23.1M, a 21.6% decline year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $23.1M -$6.37M -21.6% Sep 30, 2024 10-Q 2024-11-06
Q2 2024 $22.6M -$5.43M -19.4% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $23M -$5.48M -19.2% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $26.3M -$3.22M -10.9% Dec 31, 2023 10-Q 2024-11-06
Q3 2023 $29.5M -$360K -1.21% Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $28M -$2.41M -7.9% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $28.5M +$974K +3.54% Mar 31, 2023 10-Q 2023-05-10
Q4 2022 $29.5M +$8.95M +43.5% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $29.9M +$8.6M +40.4% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $30.4M +$8.42M +38.2% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $27.5M +$5.15M +23% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 $20.6M -$2.71M -11.6% Dec 31, 2021 10-K 2023-03-01
Q3 2021 $21.3M -$2.13M -9.09% Sep 30, 2021 10-Q 2021-11-09
Q2 2021 $22M -$1.92M -8.02% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $22.4M -$10.1M -31.2% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $23.3M -$10M -30.1% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $23.4M -$12.4M -34.7% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $23.9M -$11.1M -31.7% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $32.5M -$3.71M -10.2% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $33.3M Dec 31, 2019 10-K 2021-03-01
Q3 2019 $35.8M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $35.1M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $36.2M Mar 31, 2019 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.